• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monitoring Direct Oral Anticoagulants: Longing for the Days When We Were in Control?

作者信息

Pollak P Timothy, Mitchell L Brent

机构信息

Department of Cardiac Sciences and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.

Department of Cardiac Sciences and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.

出版信息

Can J Cardiol. 2019 Jun;35(6):694-698. doi: 10.1016/j.cjca.2019.04.009. Epub 2019 Apr 18.

DOI:10.1016/j.cjca.2019.04.009
PMID:31151700
Abstract
摘要

相似文献

1
Monitoring Direct Oral Anticoagulants: Longing for the Days When We Were in Control?监测直接口服抗凝剂：怀念我们能掌控一切的日子？
Can J Cardiol. 2019 Jun;35(6):694-698. doi: 10.1016/j.cjca.2019.04.009. Epub 2019 Apr 18.
2
Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者的直接口服抗凝剂与心血管预防
Expert Opin Pharmacother. 2017 Jan;18(1):67-77. doi: 10.1080/14656566.2016.1267140. Epub 2016 Dec 15.
3
Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion.心房颤动患者电复律时直接口服抗凝剂的管理。
Medicina (Kaunas). 2019 Sep 30;55(10):660. doi: 10.3390/medicina55100660.
4
Use of oral anticoagulants in complex clinical situations with atrial fibrillation.在伴有房颤的复杂临床情况下使用口服抗凝药物。
Med Clin (Barc). 2018 Jun;150 Suppl 1:8-24. doi: 10.1016/S0025-7753(18)30666-3.
5
Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?对于肥厚型心肌病合并心房颤动的患者，直接口服抗凝剂能否替代维生素K拮抗剂？
Int J Cardiol. 2018 Apr 1;256:39. doi: 10.1016/j.ijcard.2017.10.113.
6
Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.心房颤动消融术前后口服抗凝药的使用：关于围手术期心房颤动消融术预防血栓栓塞的个体口服抗凝药使用的当前证据综述
J Cardiovasc Electrophysiol. 2014 Dec;25(12):1411-8. doi: 10.1111/jce.12546. Epub 2014 Oct 10.
7
Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动缺血性卒中患者口服抗凝剂的选择
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2627-2631. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.036. Epub 2018 Jun 30.
8
Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者直接口服抗凝药监测与逆转的当前及发展中的策略
Hosp Pract (1995). 2015;43(5):258-67. doi: 10.1080/21548331.2015.1103190. Epub 2015 Nov 11.
9
Novel anticoagulants for non-valvular atrial fibrillation.新型非瓣膜性心房颤动抗凝药物。
Heart Lung Circ. 2012 Aug;21(8):463-7. doi: 10.1016/j.hlc.2012.04.002. Epub 2012 Apr 27.
10
Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study.老年房颤患者口服抗凝药的类型和剂量以及抗凝治疗的依从性：ESPARTA研究
J Comp Eff Res. 2018 Mar;7(3):223-232. doi: 10.2217/cer-2017-0034. Epub 2018 Feb 21.

引用本文的文献

1
Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?血浆利伐沙班水平用于识别药物暴露过量风险患者：单次药物水平测量是否可靠？
TH Open. 2021 Feb 25;5(1):e84-e88. doi: 10.1055/s-0040-1721734. eCollection 2021 Jan.
2
Carbamazepine Induction Impacting Apixaban Concentrations: A Case Report.卡马西平诱导对阿哌沙班浓度的影响：一例报告
CJC Open. 2020 May 1;2(5):423-425. doi: 10.1016/j.cjco.2020.04.009. eCollection 2020 Sep.
3
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care.
药物相互作用和遗传药理学因素导致常规治疗中房颤患者阿哌沙班浓度的变化。
J Thromb Thrombolysis. 2020 Feb;49(2):294-303. doi: 10.1007/s11239-019-01962-2.